839
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Immediate release of ibuprofen from Fujicalin®-based fast-dissolving self-emulsifying tablets

, , , , , , , , , & show all
Pages 1298-1305 | Received 02 Mar 2010, Accepted 07 Mar 2011, Published online: 11 Apr 2011

References

  • Cui S, Zhao C, Chen D, He Z. (2005). Self-microemulsifying drug delivery systems (SMEDDS) for improving in vitro dissolution and oral absorption of Pueraria lobata isoflavone. Drug Dev Ind Pharm, 31:349–356.
  • Patel D, Sawant KK. (2007). Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Dev Ind Pharm, 33:1318–1326.
  • Shah NH, Carvajal MT, Patel CI, Infield MH, Malick AW. (1994). Self-emulsifying drug delivery systems (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm, 106:15–23.
  • Wei L, Sun P, Nie S, Pan W. (2005). Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev Ind Pharm, 31:785–794.
  • Wu X, Xu J, Huang X, Wen C. (2011). Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability. Drug Dev Ind Pharm, 37:15–23.
  • Tang J. (2007). Self-emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drugs. Curr Drug Ther, 2:85–93.
  • Gursoy RN, Benita S. (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother, 58:173–182.
  • Pouton CW. (1997). Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev 25:47–58.
  • Kyatanwar AU, Jadhav KR, Kadam VJ. (2010). Self microemulsifying drug delivery system (SMEDDS): review. J Pharm Res, 3:75–83.
  • Prajapati BG, Patel MM. (2007). Conventional and alternative pharmaceutical methods to improve oral bioavailability of lipophilic drugs. Asian J Pharm, 1:1–8.
  • Tang B, Cheng G, Gu JC, Xu CH. (2008). Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov Today, 13:606–612.
  • Attama AA, Nzekwe IT, Nnamani PO, Adikwu MU, Onugu CO. (2003). The use of solid self-emulsifying systems in the delivery of diclofenac. Int J Pharm, 262:23–28.
  • Gupta MK, Goldman D, Bogner RH, Tseng YC. (2001). Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent. Pharm Dev Technol, 6:563–572.
  • Ito Y, Kusawake T, Ishida M, Tawa R, Shibata N, Takada K. (2005a). Oral solid gentamicin preparation using emulsifier and adsorbent. J Control Release, 105:23–31.
  • Ito Y, Arai H, Uchino K, Iwasaki K, Shibata N, Takada K. (2005b). Effect of adsorbents on the absorption of lansoprazole with surfactant. Int J Pharm, 289:69–77.
  • Nazzal S, Nutan M, Palamakula A, Shah R, Zaghloul AA, Khan MA. (2002). Optimization of a self-nanoemulsified tablet dosage form of ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm, 240:103–114.
  • Spireas S, Sadu S, Grover R. (1998). In vitro release evaluation of hydrocortisone liquisolid tablets. J Pharm Sci, 87:867–872.
  • Patil P, Paradkar A. (2006). Porous polystyrene beads as carriers for self-emulsifying system containing loratadine. AAPS Pharmscitech, 7:E28.
  • Venkatesan N, Yoshimitsu J, Ito Y, Shibata N, Takada K. (2005). Liquid filled nanoparticles as a drug delivery tool for protein therapeutics. Biomaterials, 26:7154–7163.
  • Cannon JB. (2005). Oral solid dosage forms of lipid-based drug delivery systems. Am Pharmaceut Rev, 8:108–117.
  • Franceschinis E, Voinovich D, Grassi M, Perissutti B, Filipovic-Grcic J, Martinac A et al. (2005). Self-emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption. Int J Pharm, 291:87–97.
  • Sander C, Holm P. (2009). Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation. AAPS Pharmscitech, 10:1388–1395.
  • Schlack H, Bauer-Brandl A, Schubert R, Becker D. (2001). Properties of Fujicalin, a new modified anhydrous dibasic calcium phosphate for direct compression: comparison with dicalcium phosphate dihydrate. Drug Dev Ind Pharm, 27:789–801.
  • Rowe RC, Sheskey PJ, Weller PJ. (2003). Handbook of Pharmaceutical Excipients, 4th Edition. London: Pharmaceutical Press, pp. 72–73.
  • Moore N. (2003). Forty years of ibuprofen use. Int J Clin Pract Suppl, 135:28–31.
  • Perrault M, Bertrand F, Chaouki J. (2011). An experimental investigation of the effect of the amount of lubricant on tablet properties. Drug Dev Ind Pharm, 37:234–242.
  • Kommuru TR, Gurley B, Khan MA, Reddy IK. (2001). Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm, 212:233–246.
  • Nakajima H. (1997). In: Solans C, Kunieda H, eds. Industrial Applications of Microemulsions. New York: Marcel Dekker, pp. 157–197.
  • Gao P, Witt MJ, Haskell RJ, Zamora KM, Shifflett JR. (2004a). Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load. Pharm Dev Technol, 9:301–309.
  • Gao P, Guyton ME, Huang T, Bauer JM, Stefanski KJ, Lu Q. (2004b). Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations. Drug Dev Ind Pharm, 30:221–229.
  • Ahmad AL, Sumathi S, Hameed BH. (2005). Adsorption of residue oil from palm oil mill effluent using powder and flake chitosan: equilibrium and kinetic studies. Water Res, 39:2483–2494.
  • Ito Y, Kusawake T, Prasad YV, Sugioka N, Shibata N, Takada K. (2006). Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies. Int J Pharm, 317:114–119.
  • Zhao N, Augsburger LL. (2005). The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets. AAPS Pharmscitech, 6:120–126.
  • Shangraw RF, Mitrevej A, Shah M. (1980). A new era of tablet disintegrants. Pharm Technol, 4:49–57.
  • Desai DS, Rubiski BA, Varia SA, Newman AW. (1993). Physical interactions of magnesium stearate with starch-derived disintegrants and their effects on capsule and tablet dissolution. Int J Pharm, 91:217–226.
  • Levy G, Antkowiak JM, Procknal JA, White DC. (1963). Effect of certain tablet formulation factors on dissolution rate of the active ingredient. II. Granule size, starch concentration, and compression pressure. J Pharm Sci, 52:1047–1051.
  • Mohrle R. (1980). Effervescent tablets. In: Lieberman HA, Lachman L, eds. Pharmaceutical Dosage Forms. New York: Marcel Dekker, pp. 225–258.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.